Invasive Haemophilus influenzae disease. Spain 2024

Authors

  • María de Viarce Torres de Mier Instituto de Salud Carlos III, Centro Nacional de Epidemiología. Madrid, España. , Centro de Investigación Biomédica en red Epidemiología y Salud Pública CIBERESP, España
  • Josefa Masa-Calles Instituto de Salud Carlos III, Centro Nacional de Epidemiología. Madrid, España. , Centro de Investigación Biomédica en red Epidemiología y Salud Pública CIBERESP, España
  • Rosa Cano Portero Instituto de Salud Carlos III, Centro Nacional de Epidemiología. Madrid, España. , Centro de Investigación Biomédica en red Epidemiología y Salud Pública CIBERESP, España

DOI:

https://doi.org/10.4321/s2173-92772026000200005

Keywords:

Invasive disease by Haemophilus influenzae; Haemophilus influenzae; Spain; Epidemiological analysis; 2024

Abstract

Introduction: Epidemiological analysis of invasive Haemophilus influenzae disease (IHD) in Spain during 2024 and its comparison with previous years (2015-2023).

Method: Descriptive epidemiological analysis of IHD cases reported to the National Epidemiological Surveillance Network (RENAVE) in 2024. The variables analyzed were: sex, age group, date of onset of symptoms, reporting region, death, clinical manifestation, and serotype.

Results: In 2024, 769 cases of HIE were reported (54% men) with a cumulative incidence rate of 1.58 (number of cases per 100,000 inhabitants). The highest incidence rates in 2024 were observed in children under 1 year of age and in the population aged 85 years and over. Typical seasonal pattern of this disease was observed, with a higher number of cases of HIE in autumn and winter. The most frequent clinical manifestation, regardless of age, was bacteremic pneumonia (49,0% of cases); 83.7% of deaths occurred in the 65-year-old age group. The serotype of most reported cases of HIE is unknown.

Discussion: In 2024, the highest cumulative incidence in the last 10 years was recorded. Improved reporting of microbiological characterization data is crucial for conducting surveillance of this disease and for evaluation of the vaccination program.

Downloads

Download data is not yet available.

References

Centro Nacional de Epidemiología. Instituto de Salud Carlos III. Red Nacional de Vigilancia Epidemiológica. Protocolos de la Red Nacional de Vigilancia Epidemiológica. Madrid: Instituto de Salud Carlos III; 2013. [Cited 2026 Jan 20]. Available from: https://cne.isciii.es/documents/d/cne/protocolo-de-vigilancia-de-enfermedad-invasora-por-haemophilus-influenzae-pdf

Limia Sánchez A, Olmedo Lucerón C, Soler Soneira M, Cantero Gudino E, Sánchez-Cambronero Cejudo L. Ponencia de Programa y Registro de Vacunaciones y evolución del calendario de vacunación en España. Rev Esp Salud Publica. 2020;94: e202003018.

Ministerio de Sanidad. Calendario común de vacunación a lo largo de toda la vida. Calendario recomendado año 2026 [Internet]. Madrid: Ministerio de Sanidad; 2026. Available from: https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/calendario/docs/CalendarioVacunacion_Todalavida.pdf

Ministerio de Sanidad. Vacunación específica en personas adultas (≥18 años) con condiciones de riesgo [Internet]. Madrid: Ministerio de Sanidad; 2026. Available from: https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/calendario/docs/CalendarioVacunacion_GRadultos.pdf

Ministerio de Sanidad. Vacunación específica en menores y adolescentes (<18 años) con condiciones de riesgo. Calendario recomendado año 2026 [Internet]. Madrid: Ministerio de Sanidad; 2026. Available from: https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/calendario/docs/CalendarioVacunacion_GRinfantil.pdf

European Centre for Disease Prevention and Control. TESSy metadata report [Internet].Stockholm: ECDC. Available from: https://www.ecdc.europa.eu/en/publications-data/tessy-metadata-report

European Parliament, Council of the European Union. Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data (General Data Protection Regulation). Off J Eur Union. 2016;59(L119):1-88.

España. Ley Orgánica 3/2018, de 5 de diciembre, de Protección de Datos Personales y garantía de los derechos digitales. Boletín Oficial del Estado. 2018 Dec 6;(294): 119788-857.

Instituto de Salud Carlos III. Vigilancia de Infección Respiratoria Aguda: gripe, COVID-19 y VRS. Semana 02/2026 (del 5 de enero al 11 de enero de 2026). Madrid: Instituto de Salud Carlos III; 2026. [Cited 2026 Jan 20]. Available from: https://repisalud.isciii.es/entities/publication/5287ed3c-1b36-4173-9145-97adc5c3a17e

Soler-Soneira M, Granero Melcón B, Arroyo Nebreda V, Sastre García M, Amillategui-Dos-Santos R, Cano Portero R. Enfermedad invasiva por Haemophilus influenzae. España 2021-2022. Boletín Epidemiológico Semanal. 2023;31(3):201-214. doi: 10.4321/s2173-92772023000300005

Soler-Soneira M, Granero-Melcón B, Sastre-García M, Bertrán-Pérez-Hickman M, Amillategui-Dos-Santos R, Cano-Portero R. Enfermedad Neumocócica Invasiva en España en 2022. Boletín Epidemiológico Semanal. 2023;31(4):260-273. doi: 10.4321/s2173-92772023000400006

Soler-Soneira M, Muñoz-Martinez L, Alcaide-Jimenez A, Arroyo Nebreda V, Cano Portero R. Enfermedad invasiva por Haemophilus influenzae. España 2023. Boletín Epidemiológico Semanal. 2024;32(3):137-149. doi: 10.4321/s2173-92772024000300004

Editorial. Patterns of respiratory infections after COVID-19. Lancet Respir Med. 2024 Jan;12(1):1 Available from: https://www.sciencedirect.com/science/article/abs/pii/S2213260023004721?via%3Dihub

European Centre for Disease Prevention and Control. Annual Epidemiological Report for 2023: Haemophilus influenzae disease [Internet]. Stockholm: ECDC; 2025. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/HAEINF_AER_2023_Report.pdf

Allonce, J., Ahsan, M., Browne, A., Witherell, R., & Rasnake, M. Changing Landscape of Haemophilus influenzae Meningitis and Implication on Public Health. Case Rep Infect Dis. 2024; 2024: 5571104. Available from: doi.org/10.1155/2024/5571104

Ministerio de Sanidad. Sistema de Información de Vacunaciones (SIVAMIN) [Internet]. Madrid: Ministerio de Sanidad. Available from: https://pestadistico.inteligenciadegestion.sanidad.gob.es/publicoSNS/I/sivamin/sivamin

Kastrin T, Paragi M, Kolman J, Cizman M, Kraigher A, Gubina M. Characterisation of invasive Haemophilus influenzae isolates in Slovenia, 1993–2008. Eur J Clin Microbiol Infect Dis. 2010;29(6):661-668. Available from: https://pubmed.ncbi.nlm.nih.gov/20306323/

Reilly AS, McElligott M, Mac Dermott Casement C, Drew RJ. Haemophilus influenzae type f in the post-Haemophilus influenzae type b vaccination era: a systematic review. J Med Microbiol. 2022;71(10). Available from: https://pubmed.ncbi.nlm.nih.gov/36306238/

Toor J, Echeverria-Londono S, Li X, Abbas K, Carter ED, Clapham HE, et al. Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world. eLife. 2021;10: e67635. Available from: https://pubmed.ncbi.nlm.nih.gov/34253291/

Whittaker R, Economopoulou A, Dias JG, Bancroft E, Ramliden M, Celentano LP. Epidemiology of invasive Haemophilus influenzae disease, Europe, 2007–2014. Emerg Infect Dis. 2017 Mar;23(3):396–404. Available from: https://pubmed.ncbi.nlm.nih.gov/28220749/

Georges S, Lepoutre A, Dabernat H, Levy-Bruhl D. Impact of Haemophilus influenzae type b vaccination on the incidence of invasive Haemophilus influenzae disease in France, 15 years after its introduction. Epidemiol Infect. 2013;141(9):1787-1796. Available from: https://pubmed.ncbi.nlm.nih.gov/23425638

Behrouzi A, Vaziri F, Rahimi-Jamnani F, Afrough P, Rahbar M, Satarian F, Siadat SD. Vaccine candidates against nontypeable Haemophilus influenzae:a review. Iran Biomed J.2017;21(2):69-76.

Galgani I, Annaratone M, Casula D, Di Maro G, Janssens M, Tasciotti A, et al. Safety and immunogenicity of three doses of non-typeable Haemophilus influenzae–Moraxella catarrhalis (NTHi–Mcat) vaccine when administered according to two different schedules: a phase 2, randomised, observer-blind study. Respir Res. 2022; 23:114.

Published

2026-07-01

Issue

Section

Epidemiological Studies

How to Cite

1.
Invasive Haemophilus influenzae disease. Spain 2024. BES [Internet]. 2026 Jul. 1 [cited 2026 Nov. 20];34(2):86-99. Available from: https://revista.isciii.es/index.php/bes/article/view/1513